Global Musculoskeletal Medicine Market Size, Status and Forecast 2020-2026
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Musculoskeletal Medicine Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Musculoskeletal Medicine Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Tablets
- 1.4.3 Patch
- 1.4.4 Capsule
- 1.4.5 Suppositories
- 1.4.6 Injection
- 1.4.7 Suspension Agent
- 1.4.8 Emplastrum
- 1.4.9 Granules
- 1.4.10 Other
- 1.5 Market by Application
- 1.5.1 Global Musculoskeletal Medicine Market Share by Application: 2020 VS 2026
- 1.5.2 Orthopedic Analgesics
- 1.5.3 Antipyretic And Analgesic
- 1.5.4 Nonsteroidal Anti-Inflammatory Drugs
- 1.5.5 Drugs For Rheumatic Diseases
- 1.5.6 Gout Drug Resistance
- 1.5.7 Medication For Bruising Injuries
- 1.5.8 Myasthenia Gravis Medication
- 1.5.9 Slow Acting Antirheumatic Agent
- 1.5.10 Topical Administration For Joint And Muscle Pain
- 1.5.11 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends by Regions
- 2.1 Musculoskeletal Medicine Market Perspective (2015-2026)
- 2.2 Musculoskeletal Medicine Growth Trends by Regions
- 2.2.1 Musculoskeletal Medicine Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Musculoskeletal Medicine Historic Market Share by Regions (2015-2020)
- 2.2.3 Musculoskeletal Medicine Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Musculoskeletal Medicine Market Growth Strategy
- 2.3.6 Primary Interviews with Key Musculoskeletal Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Musculoskeletal Medicine Players by Market Size
- 3.1.1 Global Top Musculoskeletal Medicine Players by Revenue (2015-2020)
- 3.1.2 Global Musculoskeletal Medicine Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Musculoskeletal Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Musculoskeletal Medicine Market Concentration Ratio
- 3.2.1 Global Musculoskeletal Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Musculoskeletal Medicine Revenue in 2019
- 3.3 Musculoskeletal Medicine Key Players Head office and Area Served
- 3.4 Key Players Musculoskeletal Medicine Product Solution and Service
- 3.5 Date of Enter into Musculoskeletal Medicine Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Musculoskeletal Medicine Historic Market Size by Type (2015-2020)
- 4.2 Global Musculoskeletal Medicine Forecasted Market Size by Type (2021-2026)
5 Musculoskeletal Medicine Breakdown Data by Application (2015-2026)
- 5.1 Global Musculoskeletal Medicine Market Size by Application (2015-2020)
- 5.2 Global Musculoskeletal Medicine Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Musculoskeletal Medicine Market Size (2015-2020)
- 6.2 Musculoskeletal Medicine Key Players in North America (2019-2020)
- 6.3 North America Musculoskeletal Medicine Market Size by Type (2015-2020)
- 6.4 North America Musculoskeletal Medicine Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Musculoskeletal Medicine Market Size (2015-2020)
- 7.2 Musculoskeletal Medicine Key Players in Europe (2019-2020)
- 7.3 Europe Musculoskeletal Medicine Market Size by Type (2015-2020)
- 7.4 Europe Musculoskeletal Medicine Market Size by Application (2015-2020)
8 China
- 8.1 China Musculoskeletal Medicine Market Size (2015-2020)
- 8.2 Musculoskeletal Medicine Key Players in China (2019-2020)
- 8.3 China Musculoskeletal Medicine Market Size by Type (2015-2020)
- 8.4 China Musculoskeletal Medicine Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Musculoskeletal Medicine Market Size (2015-2020)
- 9.2 Musculoskeletal Medicine Key Players in Japan (2019-2020)
- 9.3 Japan Musculoskeletal Medicine Market Size by Type (2015-2020)
- 9.4 Japan Musculoskeletal Medicine Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Musculoskeletal Medicine Market Size (2015-2020)
- 10.2 Musculoskeletal Medicine Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Musculoskeletal Medicine Market Size by Type (2015-2020)
- 10.4 Southeast Asia Musculoskeletal Medicine Market Size by Application (2015-2020)
11 India
- 11.1 India Musculoskeletal Medicine Market Size (2015-2020)
- 11.2 Musculoskeletal Medicine Key Players in India (2019-2020)
- 11.3 India Musculoskeletal Medicine Market Size by Type (2015-2020)
- 11.4 India Musculoskeletal Medicine Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Musculoskeletal Medicine Market Size (2015-2020)
- 12.2 Musculoskeletal Medicine Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Musculoskeletal Medicine Market Size by Type (2015-2020)
- 12.4 Central & South America Musculoskeletal Medicine Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Mylan N.V.
- 13.1.1 Mylan N.V. Company Details
- 13.1.2 Mylan N.V. Business Overview and Its Total Revenue
- 13.1.3 Mylan N.V. Musculoskeletal Medicine Introduction
- 13.1.4 Mylan N.V. Revenue in Musculoskeletal Medicine Business (2015-2020))
- 13.1.5 Mylan N.V. Recent Development
- 13.2 Teva Pharmaceutical Industries Ltd
- 13.2.1 Teva Pharmaceutical Industries Ltd Company Details
- 13.2.2 Teva Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
- 13.2.3 Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Introduction
- 13.2.4 Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.2.5 Teva Pharmaceutical Industries Ltd Recent Development
- 13.3 UCB S.A.
- 13.3.1 UCB S.A. Company Details
- 13.3.2 UCB S.A. Business Overview and Its Total Revenue
- 13.3.3 UCB S.A. Musculoskeletal Medicine Introduction
- 13.3.4 UCB S.A. Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.3.5 UCB S.A. Recent Development
- 13.4 Novartis Pharmaceuticals
- 13.4.1 Novartis Pharmaceuticals Company Details
- 13.4.2 Novartis Pharmaceuticals Business Overview and Its Total Revenue
- 13.4.3 Novartis Pharmaceuticals Musculoskeletal Medicine Introduction
- 13.4.4 Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.4.5 Novartis Pharmaceuticals Recent Development
- 13.5 Roche Inc
- 13.5.1 Roche Inc Company Details
- 13.5.2 Roche Inc Business Overview and Its Total Revenue
- 13.5.3 Roche Inc Musculoskeletal Medicine Introduction
- 13.5.4 Roche Inc Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.5.5 Roche Inc Recent Development
- 13.6 Hospira Inc
- 13.6.1 Hospira Inc Company Details
- 13.6.2 Hospira Inc Business Overview and Its Total Revenue
- 13.6.3 Hospira Inc Musculoskeletal Medicine Introduction
- 13.6.4 Hospira Inc Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.6.5 Hospira Inc Recent Development
- 13.7 Valeant Pharmaceuticals International, Inc
- 13.7.1 Valeant Pharmaceuticals International, Inc Company Details
- 13.7.2 Valeant Pharmaceuticals International, Inc Business Overview and Its Total Revenue
- 13.7.3 Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Introduction
- 13.7.4 Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.7.5 Valeant Pharmaceuticals International, Inc Recent Development
- 13.8 Dr. Reddy's Laboratories Ltd.
- 13.8.1 Dr. Reddy's Laboratories Ltd. Company Details
- 13.8.2 Dr. Reddy's Laboratories Ltd. Business Overview and Its Total Revenue
- 13.8.3 Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Introduction
- 13.8.4 Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.8.5 Dr. Reddy's Laboratories Ltd. Recent Development
- 13.9 Sun Pharmaceutical Industries Ltd. Co. , Ltd
- 13.9.1 Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Details
- 13.9.2 Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview and Its Total Revenue
- 13.9.3 Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Introduction
- 13.9.4 Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.9.5 Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development
- 13.10 Sawai PharmaceuticalCo., Ltd
- 13.10.1 Sawai PharmaceuticalCo., Ltd Company Details
- 13.10.2 Sawai PharmaceuticalCo., Ltd Business Overview and Its Total Revenue
- 13.10.3 Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Introduction
- 13.10.4 Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2015-2020)
- 13.10.5 Sawai PharmaceuticalCo., Ltd Recent Development
- 13.11 Endo International
- 10.11.1 Endo International Company Details
- 10.11.2 Endo International Business Overview and Its Total Revenue
- 10.11.3 Endo International Musculoskeletal Medicine Introduction
- 10.11.4 Endo International Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.11.5 Endo International Recent Development
- 13.12 Hikma Pharmaceuticals
- 10.12.1 Hikma Pharmaceuticals Company Details
- 10.12.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
- 10.12.3 Hikma Pharmaceuticals Musculoskeletal Medicine Introduction
- 10.12.4 Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.12.5 Hikma Pharmaceuticals Recent Development
- 13.13 Fresenius Kabi, LLC
- 10.13.1 Fresenius Kabi, LLC Company Details
- 10.13.2 Fresenius Kabi, LLC Business Overview and Its Total Revenue
- 10.13.3 Fresenius Kabi, LLC Musculoskeletal Medicine Introduction
- 10.13.4 Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.13.5 Fresenius Kabi, LLC Recent Development
- 13.14 Boehringer Ingelheim
- 10.14.1 Boehringer Ingelheim Company Details
- 10.14.2 Boehringer Ingelheim Business Overview and Its Total Revenue
- 10.14.3 Boehringer Ingelheim Musculoskeletal Medicine Introduction
- 10.14.4 Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.14.5 Boehringer Ingelheim Recent Development
- 13.15 Merck
- 10.15.1 Merck Company Details
- 10.15.2 Merck Business Overview and Its Total Revenue
- 10.15.3 Merck Musculoskeletal Medicine Introduction
- 10.15.4 Merck Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.15.5 Merck Recent Development
- 13.16 GSK
- 10.16.1 GSK Company Details
- 10.16.2 GSK Business Overview and Its Total Revenue
- 10.16.3 GSK Musculoskeletal Medicine Introduction
- 10.16.4 GSK Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.16.5 GSK Recent Development
- 13.17 Alter
- 10.17.1 Alter Company Details
- 10.17.2 Alter Business Overview and Its Total Revenue
- 10.17.3 Alter Musculoskeletal Medicine Introduction
- 10.17.4 Alter Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.17.5 Alter Recent Development
- 13.18 Bayer
- 10.18.1 Bayer Company Details
- 10.18.2 Bayer Business Overview and Its Total Revenue
- 10.18.3 Bayer Musculoskeletal Medicine Introduction
- 10.18.4 Bayer Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.18.5 Bayer Recent Development
- 13.19 Rafa Laboratories
- 10.19.1 Rafa Laboratories Company Details
- 10.19.2 Rafa Laboratories Business Overview and Its Total Revenue
- 10.19.3 Rafa Laboratories Musculoskeletal Medicine Introduction
- 10.19.4 Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.19.5 Rafa Laboratories Recent Development
- 13.20 Grunenthal
- 10.20.1 Grunenthal Company Details
- 10.20.2 Grunenthal Business Overview and Its Total Revenue
- 10.20.3 Grunenthal Musculoskeletal Medicine Introduction
- 10.20.4 Grunenthal Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.20.5 Grunenthal Recent Development
- 13.21 Pfizer
- 10.21.1 Pfizer Company Details
- 10.21.2 Pfizer Business Overview and Its Total Revenue
- 10.21.3 Pfizer Musculoskeletal Medicine Introduction
- 10.21.4 Pfizer Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.21.5 Pfizer Recent Development
- 13.22 Sanofi
- 10.22.1 Sanofi Company Details
- 10.22.2 Sanofi Business Overview and Its Total Revenue
- 10.22.3 Sanofi Musculoskeletal Medicine Introduction
- 10.22.4 Sanofi Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.22.5 Sanofi Recent Development
- 13.23 Italfarmaco
- 10.23.1 Italfarmaco Company Details
- 10.23.2 Italfarmaco Business Overview and Its Total Revenue
- 10.23.3 Italfarmaco Musculoskeletal Medicine Introduction
- 10.23.4 Italfarmaco Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.23.5 Italfarmaco Recent Development
- 13.24 Martec USA LLC
- 10.24.1 Martec USA LLC Company Details
- 10.24.2 Martec USA LLC Business Overview and Its Total Revenue
- 10.24.3 Martec USA LLC Musculoskeletal Medicine Introduction
- 10.24.4 Martec USA LLC Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.24.5 Martec USA LLC Recent Development
- 13.25 Acorda Therapeutics
- 10.25.1 Acorda Therapeutics Company Details
- 10.25.2 Acorda Therapeutics Business Overview and Its Total Revenue
- 10.25.3 Acorda Therapeutics Musculoskeletal Medicine Introduction
- 10.25.4 Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.25.5 Acorda Therapeutics Recent Development
- 13.26 Apotex Inc
- 10.26.1 Apotex Inc Company Details
- 10.26.2 Apotex Inc Business Overview and Its Total Revenue
- 10.26.3 Apotex Inc Musculoskeletal Medicine Introduction
- 10.26.4 Apotex Inc Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.26.5 Apotex Inc Recent Development
- 13.27 CorePharma
- 10.27.1 CorePharma Company Details
- 10.27.2 CorePharma Business Overview and Its Total Revenue
- 10.27.3 CorePharma Musculoskeletal Medicine Introduction
- 10.27.4 CorePharma Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.27.5 CorePharma Recent Development
- 13.28 Helsinn
- 10.28.1 Helsinn Company Details
- 10.28.2 Helsinn Business Overview and Its Total Revenue
- 10.28.3 Helsinn Musculoskeletal Medicine Introduction
- 10.28.4 Helsinn Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.28.5 Helsinn Recent Development
- 13.29 Therabel
- 10.29.1 Therabel Company Details
- 10.29.2 Therabel Business Overview and Its Total Revenue
- 10.29.3 Therabel Musculoskeletal Medicine Introduction
- 10.29.4 Therabel Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.29.5 Therabel Recent Development
- 13.30 Sinopharm
- 10.30.1 Sinopharm Company Details
- 10.30.2 Sinopharm Business Overview and Its Total Revenue
- 10.30.3 Sinopharm Musculoskeletal Medicine Introduction
- 10.30.4 Sinopharm Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.30.5 Sinopharm Recent Development
- 13.31 Chinoin
- 10.31.1 Chinoin Company Details
- 10.31.2 Chinoin Business Overview and Its Total Revenue
- 10.31.3 Chinoin Musculoskeletal Medicine Introduction
- 10.31.4 Chinoin Revenue in Musculoskeletal Medicine Business (2015-2020)
- 10.31.5 Chinoin Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
This report focuses on the global Musculoskeletal Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Mylan N.V.
Teva Pharmaceutical Industries Ltd
UCB S.A.
Novartis Pharmaceuticals
Roche Inc
Hospira Inc
Valeant Pharmaceuticals International, Inc
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd. Co. , Ltd
Sawai PharmaceuticalCo., Ltd
Endo International
Hikma Pharmaceuticals
Fresenius Kabi, LLC
Boehringer Ingelheim
Merck
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Martec USA LLC
Acorda Therapeutics
Apotex Inc
CorePharma
Helsinn
Therabel
Sinopharm
Chinoin
Market segment by Type, the product can be split into
by Dosage Form
Tablets
Patch
Capsule
Suppositories
Injection
Suspension Agent
Emplastrum
Granules
Other
by Route
Oral
Intravenous
Topical
Market segment by Application, split into
Orthopedic Analgesics
Antipyretic And Analgesic
Nonsteroidal Anti-Inflammatory Drugs
Drugs For Rheumatic Diseases
Gout Drug Resistance
Medication For Bruising Injuries
Myasthenia Gravis Medication
Slow Acting Antirheumatic Agent
Topical Administration For Joint And Muscle Pain
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Musculoskeletal Medicine status, future forecast, growth opportunity, key market and key players.
To present the Musculoskeletal Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Musculoskeletal Medicine are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.